Restructuring the Alpha-Gamma Code in Aging Vision
Boston University Charles River Campus · NCT07208318
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Early Phase 1
- Target enrollment
- 240
- US sites recruiting
- 1
- Study start
- April 2, 2026
- Record last updated
- July 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Tests whether age-related visual deficits arise from disrupted alpha-gamma coupling in visual cortex (V1) and MT. Uses fMRI, source-resolved HD-EEG, and personalized complex-waveform HD-tACS to (1) quantify aging effects on phase-amplitude coupling, (2) drive PAC into a preferred "gamma-at-alpha-troughs" state, and (3) bidirectionally change perception by aligning gamma to alpha troughs vs peaks. Two five-day, double-blind, sham-controlled studies (n=120 each) target contrast sensitivity (V1) and 3D shape-from-motion (MT), aiming for mechanistic insight and remediation in older adults with implications for ADRD.
Being studied: High definition transcranial electrical current stimulation
Conditions: Aging; Visual Perception; Noninvasive Brain Stimulation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- 18+ years of age or older
- normal or corrected-to-normal visual acuity, color vision, and stereo vision
Exclusion Criteria
- not pregnant,
- no metal implants in head,
- no implanted electronic devices,
- no history of neurological problems or head injury,
- no skin sensitivity,
- no claustrophobia,
- no dementia (normal Mini Mental State Examination between 24-30; Montreal Cognitive Assessment > 25)
- no depression (normal Beck Depression Inventory II \<13; Geriatric Depression Scale \< 10)
- no ophthalmological diseases (e.g., strabismus, glaucoma, cataract, macular degeneration)
- no history of psychosis
- no cognitive deficits (MMSE score>24; MoCA>25)
- cannot be taking any psychoactive medication.
Recruiting US locations
111 Cummington Mall, Boston University
Boston, MA 02215
Site contact: Robert Reinhart, PhD · 617-353-9481 · rmgr@bu.edu
Study contacts (from the official record)
- Robert Reinhart, PhD · (617) 353-9481 · rmgr@bu.edu
Similar studies in Massachusetts
All healthy volunteers studies in Massachusetts →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Mabylon AG
- Location
- Boston, MA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
Haya Therapeutics, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Boston, MA + 49 other US sites
- Eligibility basics
- Ages 60+